-
Fredwall, SO, Linge, J, Leinhard, OD, Kjønigsen, L, Eggesbø, HB, Weedon-Fekjær, H, Lidal, IB, Månum, G, Savarirayan, R, Tonstad, S.
Correction to: Cardiovascular risk factors and body composition in adults with achondroplasia.
Genetics in Medicine
23(11)
:
2234 -2234
2021
view publication
-
Kumble, S, Savarirayan, R.
Emerging therapies for Achondroplasia: changing the rules of the game.
Expert Opinion on Emerging Drugs
26(4)
:
425 -431
2021
view publication
-
Savarirayan, R, Irving, M, Hoover-Fong, J, Bacino, CA, Ozono, K, Mohnike, K, Cormier-Daire, V, Leiva-Gea, A, Alanay, Y, Andrews, M, et al.
Vosoritide treatment accelerates bone growth in children with achondroplasia.
Future Rare Diseases
1(3)
:
frd14
2021
view publication
-
Savarirayan, R, Tofts, L, Irving, M, Wilcox, W, Bacino, CA, Hoover-Fong, J, Font, RU, Harmatz, P, Rutsch, F, Bober, MB, et al.
Persistent and Stable Growth Promoting Effects of Vosoritide in Children With Achondroplasia for up to 2 Years: Results From the Ongoing Phase 3 Extension Study.
Journal of the Endocrine Society
5(Supplement_1)
:
a670 -a671
2021
view publication
-
Savarirayan, R, Kannu, P, Dambkowski, CL, Rogoff, D, Irving, M.
Infigratinib in Children With Achondroplasia (ACH): Design of PROPEL2 - A Phase 2, Open-Label, Dose-Escalation and Dose-Expansion Study.
Journal of the Endocrine Society
5(Supplement_1)
:
a667 -a668
2021
view publication